Wedbush Securities Inc. Trims Stock Holdings in SPDR S&P Biotech ETF $XBI

Wedbush Securities Inc. cut its stake in SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report) by 16.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 5,578 shares of the exchange traded fund’s stock after selling 1,099 shares during the period. Wedbush Securities Inc.’s holdings in SPDR S&P Biotech ETF were worth $463,000 at the end of the most recent reporting period.

A number of other institutional investors have also made changes to their positions in the company. DHJJ Financial Advisors Ltd. bought a new position in SPDR S&P Biotech ETF during the 2nd quarter worth $25,000. Garrison Bradford & Associates Inc. acquired a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $39,000. Quaker Wealth Management LLC grew its position in SPDR S&P Biotech ETF by 101.2% in the second quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 53,536 shares during the last quarter. Avalon Trust Co acquired a new stake in shares of SPDR S&P Biotech ETF during the first quarter worth $57,000. Finally, Curio Wealth LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 74,700.0% in the second quarter. Curio Wealth LLC now owns 748 shares of the exchange traded fund’s stock worth $62,000 after buying an additional 747 shares during the period.

SPDR S&P Biotech ETF Stock Up 3.6%

Shares of NYSEARCA:XBI opened at $114.01 on Wednesday. SPDR S&P Biotech ETF has a 12-month low of $66.66 and a 12-month high of $114.15. The company has a market cap of $6.92 billion, a P/E ratio of 11.47 and a beta of 0.93. The company’s fifty day moving average is $103.04 and its two-hundred day moving average is $90.94.

About SPDR S&P Biotech ETF

(Free Report)

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Featured Articles

Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBIFree Report).

Institutional Ownership by Quarter for SPDR S&P Biotech ETF (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.